1 |
Kilmister EJ, Koh SP, Weth FR, Gray C, Tan ST. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment. Biomedicines 2022;10. [PMID: 36428556 DOI: 10.3390/biomedicines10112988] [Reference Citation Analysis]
|
2 |
Hosseini-dastgerdi H, Kharazmi F, Pourshanazari A, Nematbakhsh M, Kershaw DB. Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors. International Journal of Nephrology 2022;2022:1-11. [DOI: 10.1155/2022/8731357] [Reference Citation Analysis]
|
3 |
Kapoor-Narula U, Lenka N. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis. Cytokine 2022;157:155968. [PMID: 35872504 DOI: 10.1016/j.cyto.2022.155968] [Reference Citation Analysis]
|
4 |
Kilmister EJ, Tan ST. Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System. Front Surg 2022;9:868187. [DOI: 10.3389/fsurg.2022.868187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
5 |
O'Rawe M, Wickremesekera AC, Pandey R, Young D, Sim D, FitzJohn T, Burgess C, Kaye AH, Tan ST. Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial. J Clin Neurosci 2022;95:48-54. [PMID: 34929651 DOI: 10.1016/j.jocn.2021.11.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
6 |
Parvanova I, Borziak K, Guarino J, Finkelstein J. A Platform for Integrating and Sharing Cancer Stem Cell Data. 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021. [DOI: 10.1109/embc46164.2021.9630083] [Reference Citation Analysis]
|
7 |
Humphries F, Chang-McDonald B, Patel J, Bockett N, Paterson E, Davis PF, Tan ST. Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma. Front Oncol 2021;11:690460. [PMID: 34621666 DOI: 10.3389/fonc.2021.690460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
8 |
Munro MJ, Peng L, Wickremesekera SK, Tan ST. Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors. PLoS One 2021;16:e0256280. [PMID: 34428252 DOI: 10.1371/journal.pone.0256280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
9 |
O'Rawe M, Kilmister EJ, Mantamadiotis T, Kaye AH, Tan ST, Wickremesekera AC. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma. Cancers (Basel) 2021;13:4004. [PMID: 34439159 DOI: 10.3390/cancers13164004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
10 |
Kilmister EJ, Tan ST. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche. J Histochem Cytochem 2021;:221554211026295. [PMID: 34165363 DOI: 10.1369/00221554211026295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
11 |
Siljee S, Milne B, Brasch HD, Bockett N, Patel J, Davis PF, Kennedy-Smith A, Itinteang T, Tan ST. Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma. Biomolecules 2021;11:537. [PMID: 33916968 DOI: 10.3390/biom11040537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|